Essity’s acquisition of ABIGO Medical is completed

The process following the acquisition of the remaining 25% of the shares of ABIGO Medical AB is completed and the company is now a wholly owned subsidiary of Essity. As per the terms of the transaction, ABIGO Medicals pharma business has been divested and sold to the company’s founder Jan G. Smith.

ABIGO Medical is a Swedish medical solutions company with its head office in Gothenburg, Sweden. The company has about 170 employees. Essity acquired 75% of ABIGO Medical in February 2020. ABIGO Medical develops, manufactures and markets products including the Sorbact^® technology, which is a clinically established innovation for advanced wound care. In the first quarter of 2021, Essity’s organic net sales in wound care increased 2.1%.

For further information, please contact:
Per Lorentz, Vice President Corporate Communications, +46 8 788 52 51, per.lorentz@essity.com
Johan Karlsson, Vice President Investor Relations, +46 8 788 51 30, johan.ir.karlsson@essity.com

Essity is a leading global hygiene and health company. We are dedicated to improving well-being through our products and services. Sales are conducted in approximately 150 countries under the leading global brands TENA and Tork, and other strong brands, such as JOBST, Leukoplast, Libero, Libresse, Lotus, Nosotras, Saba, Tempo, Vinda and Zewa. Essity has about 46,000 employees. Net sales in 2020 amounted to approximately SEK 122bn (EUR 11.6bn). The company’s headquarters is located in Stockholm, Sweden, and Essity is listed on Nasdaq Stockholm. Essity breaks barriers to well-being and contributes to a healthy, sustainable and circular society. More information at www.essity.com.